19 Sep 2017 07:00
RNS Number : 0613R
Immupharma PLC
19 September 2017
FOR IMMEDIATE RELEASE 19 SEPTEMBER 2017
ImmuPharma PLC
("ImmuPharma" or the "Company")
NOTIFICATION OF INTERIM RESULTS
Date: 27 September 2017
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, confirms that it will be announcing its Interim results for the six months ended 30 June 2017 on Wednesday 27 September 2017.
-Ends-
For further information please contact: ImmuPharma plc (www.immupharma.org) | + 44 (0) 20 7152 4080 | Tim McCarthy, Chairman | | Lisa Baderoon, Head of Investor Relations Twitter: @immupharma | + 44 (0) 7721 413496 | | | Northland Capital Partners Limited (Joint Broker) Patrick Claridge, David Hignell, Jamie Spotswood, Corporate Finance Rob Rees, Corporate Broking | +44 (0)20 3861 6625 | | |
| |
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORXVLFFDKFLBBQ
Immupharma (IMM)